{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:48:55Z","timestamp":1792460935898,"version":"4.5.0"},"reference-count":23,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2024,12,17]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Dasatinib is a common treatment for chronic myeloid leukaemia with numerous side effects including gastrointestinal. We report a woman in her 50s who presented with haematochezia, weight loss and a positive faecal occult blood test. She was being treated for chronic myeloid leukaemia with dasatinib without the use of any concurrent medications, including non-steroidal anti-inflammatory drugs. Initial colonoscopy demonstrated moderate patchy left-sided inflammation, with biopsies revealing mild chronic inflammation and prominent eosinophilia. Dasatinib was subsequently ceased, and a repeat colonoscopy 3 months later demonstrated completely resolved inflammation both endoscopically and histologically.<\/jats:p>","DOI":"10.1136\/bcr-2024-263646","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T22:50:38Z","timestamp":1736031038000},"page":"e263646","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Dasatinib-induced colitis in a patient with chronic myeloid leukaemia"],"prefix":"10.1136","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6947-274X","authenticated-orcid":false,"given":"Alexander Edmund","family":"Gluch","sequence":"first","affiliation":[{"name":"Department of Digestive Health, Gold Coast University Hospital, Gold Coast, Australia, Gold Coast Hospital and Health Service, Southport, Queensland, Australia"},{"name":"Department of Pathology, Gold Coast University Hospital, Gold Coast, Australia, Gold Coast Hospital and Health Service, Southport, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deloshaan","family":"Subhaharan","sequence":"additional","affiliation":[{"name":"Department of Digestive Health, Gold Coast University Hospital, Gold Coast, Australia, Gold Coast Hospital and Health Service, Southport, Queensland, Australia"},{"name":"Griffith University, Gold Coast, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sooraj","family":"Pillai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Gold Coast University Hospital, Gold Coast, Australia, Gold Coast Hospital and Health Service, Southport, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep Kakkadasam","family":"Ramaswamy","sequence":"additional","affiliation":[{"name":"Department of Digestive Health, Gold Coast University Hospital, Gold Coast, Australia, Gold Coast Hospital and Health Service, Southport, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,1,4]]},"reference":[{"key":"2025082709092960000_18.1.e263646.1","unstructured":"Eden RE , Coviello JM . Chronic myelogneous leukemia. StatPearls Treasure Island: StatPearls Publishing, 2023."},{"key":"2025082709092960000_18.1.e263646.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055229"},{"key":"2025082709092960000_18.1.e263646.3","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/cncr.32627","article-title":"Long-term results of frontline dasatinib in chronic myeloid leukemia","volume":"126","author":"Maiti","year":"2020","journal-title":"Cancer"},{"key":"2025082709092960000_18.1.e263646.4","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1113462","article-title":"Adverse reactions after treatment with dasatinib in chronic myeloid leukemia: Characteristics, potential mechanisms, and clinical management strategies","volume":"13","author":"Cheng","year":"2023","journal-title":"Front Oncol"},{"key":"2025082709092960000_18.1.e263646.5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-734947"},{"key":"2025082709092960000_18.1.e263646.6","first-page":"663","article-title":"Dasatinib-induced colitis: discovering the side effects of immunotherapy","volume":"112","author":"Jim\u00e9nez Beltr\u00e1n","year":"2020","journal-title":"Rev Esp Enferm Dig"},{"key":"2025082709092960000_18.1.e263646.7","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-020-01584-6","article-title":"Differential gene expression analysis of dasatinib-induced colitis in a patient with chronic myeloid leukemia followed for 3 years: a case report","volume":"21","author":"Oshima","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"2025082709092960000_18.1.e263646.8","first-page":"757","article-title":"Dasatinib-induced colitis: a case report","volume":"51","author":"Tamilarasan","year":"2019","journal-title":"Pathol (Phila)"},{"key":"2025082709092960000_18.1.e263646.9","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2022-208340"},{"key":"2025082709092960000_18.1.e263646.10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000481538","article-title":"Dasatinib-Induced Colitis in a Patient with Chronic Myelogenous Leukemia","volume":"25","author":"Perdigoto","year":"2018","journal-title":"GE Port J Gastroenterol"},{"key":"2025082709092960000_18.1.e263646.11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12288-015-0528-z","article-title":"A Case of Dasatinib-Induced Hemorrhagic Colitis Diagnosed by the Lymphocyte Transformation Test in a Chronic Myeloid Leukemia Patient","volume":"32","author":"Ahn","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"key":"2025082709092960000_18.1.e263646.12","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-200610","article-title":"Dasatinib-induced haemorrhagic colitis in chronic myeloid leukaemia (CML) in blast crisis","volume":"2013","author":"Chisti","year":"2013","journal-title":"BMJ Case Rep"},{"key":"2025082709092960000_18.1.e263646.13","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jfma.2020.10.009","article-title":"Cytomegalovirus colitis with presentation of hemorrhagic colitis in chronic myeloid leukemia during dasatinib therapy","volume":"120","author":"Chuang","year":"2021","journal-title":"J Formos Med Assoc"},{"key":"2025082709092960000_18.1.e263646.14","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1159\/000516794","article-title":"Dasatinib-Induced Colitis with Rectal Sparing in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy: Case Report","volume":"14","author":"Maat","year":"2021","journal-title":"Case Rep Oncol"},{"key":"2025082709092960000_18.1.e263646.15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3904\/kjim.2015.325","article-title":"Dasatinib induces severe hemorrhagic colitis in a patient with accelerated phase of chronic myelogenous leukemia","volume":"33","author":"Yim","year":"2018","journal-title":"Korean J Intern Med"},{"key":"2025082709092960000_18.1.e263646.16","doi-asserted-by":"publisher","DOI":"10.4291\/wjgp.v4.i3.59"},{"key":"2025082709092960000_18.1.e263646.17","doi-asserted-by":"publisher","DOI":"10.3109\/08880010903071295"},{"key":"2025082709092960000_18.1.e263646.18","article-title":"Haemorrhagic colitis caused by dasatinib","volume":"2012","author":"Patodi","year":"2012","journal-title":"Case Rep Hematol"},{"key":"2025082709092960000_18.1.e263646.19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/00365521.2021.2022190","article-title":"Dasatinib-induced colitis: clinical, endoscopic and histological findings","volume":"57","author":"Yamauchi","year":"2022","journal-title":"Scand J Gastroenterol"},{"key":"2025082709092960000_18.1.e263646.20","first-page":"181","article-title":"Clinical profiles of 7 patients with chronic myelogenous leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia treated with dasatinib","volume":"51","author":"Hoshino","year":"2010","journal-title":"Rinsho Ketsueki"},{"key":"2025082709092960000_18.1.e263646.21","doi-asserted-by":"crossref","first-page":"26252","DOI":"10.1038\/srep26252","article-title":"Integrin CD11b attenuates colitis by strengthening Src-Akt pathway to polarize anti-inflammatory IL-10 expression","volume":"6","author":"Hu","year":"2016","journal-title":"Sci Rep"},{"key":"2025082709092960000_18.1.e263646.22","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.46"},{"key":"2025082709092960000_18.1.e263646.23","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.018267"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-263646","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:09:41Z","timestamp":1756310981000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-263646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,4]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/bcr-2024-263646"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-263646","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}